CIK 0001041024
- Non-accelerated filer
- Smaller reporting company
ROCKWELL MEDICAL, INC.
Sign in to watch- Ticker
- RMTI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 383317208
- Phone
- +1 800-449-3353
- Business address
- 30142 WIXOM ROAD, WIXOM, MI, 48393
- Former names
- ROCKWELL MEDICAL TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $8,420
- in 1 filing, $8K under 10b5-1 plans
Net −$8,420. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-10-01 | Pratt Raymond Dennis VP of Drug Development | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2014-10-01 | HOLT KENNETH L Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2014-10-01 | Gupta Ajay Chief Scientific Officer | Grant or award | +75,000 | 380,215 | ||
| 2014-10-01 | Gupta Ajay Chief Scientific Officer | Exercise or conversion | +13,000 | $6.74 | $88K | 393,215 |
| 2014-10-01 | Gupta Ajay Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2014-10-01 | Gupta Ajay Chief Scientific Officer | Exercise or conversion · Stock Option (right to buy) | −13,000 | 187,000 | ||
| 2014-10-01 | CHIOINI ROBERT L Chairman, President and CEO | Grant or award | +200,000 | 1,828,333 | ||
| 2014-10-01 | CHIOINI ROBERT L Chairman, President and CEO | Grant or award · Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2014-10-01 | CHIOINI ROBERT L Chairman, President and CEO | Grant or award · Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2014-10-01 | BOYD RONALD D Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2014-10-01 | Bagley Patrick J Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2014-01-13 | Pratt Raymond Dennis VP of Drug Development | Grant or award | +75,000 | 150,000 | ||
| 2014-01-13 | Pratt Raymond Dennis VP of Drug Development | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2014-01-13 | KLEMA THOMAS E Vice President, CFO | Grant or award | +70,000 | 479,620 | ||
| 2014-01-13 | KLEMA THOMAS E Vice President, CFO | Grant or award · Stock Option (right to buy) | +120,000 | 120,000 | ||
| 2014-01-13 | HOLT KENNETH L Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2014-01-13 | Gupta Ajay Chief Scientific Officer | Grant or award | +75,000 | 305,215 | ||
| 2014-01-13 | Gupta Ajay Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2014-01-13 | CHIOINI ROBERT L Chairman, President and CEO | Grant or award | +100,000 | 1,628,333 | ||
| 2014-01-13 | CHIOINI ROBERT L Chairman, President and CEO | Grant or award · Stock Option (right to buy) | +250,000 | 250,000 |
Page 22 of 30 · 588 trades